Dissecting stroke for anti-VWF therapeutics. - Wikidata - wikimedia - TriplyDB

Dissecting stroke for anti-VWF therapeutics.

Dissecting stroke for anti-VWF therapeutics.

http://www.wikidata.org/entity/Q41494260

about

Dissecting stroke for anti-VWF therapeutics.

http://www.wikidata.org/entity/Q41494260

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dissecting stroke for anti-VWF therapeutics.

@en

type

label

Dissecting stroke for anti-VWF therapeutics.

@en

prefLabel

Dissecting stroke for anti-VWF therapeutics.

@en

P1433

Q41494260-06B7C396-959D-4BB6-8CF0-E2BB3D316023

P1476

Q41494260-6ED876E0-FE9B-425A-B49C-E8E0BE63B1A9

P2093

Q41494260-3129AABD-8AFD-4044-B9F5-C1FE764F8592

P2860

Q41494260-001D10BF-B7F5-420B-BFAF-F6F0D513535D

Q41494260-27F2C1BB-620B-46CC-B941-47BAA66F2BE3

Q41494260-41D47A1B-994A-4601-8419-FCFE0DD509E6

Q41494260-43F36B2F-DE29-4957-ACE9-7E16217C8EA5

Q41494260-5D65E8C1-F8F2-4ED9-87F6-C38E3323AF96

Q41494260-81D59F63-8CFA-4EDE-B206-22C0E59F4C0E

Q41494260-8A2279A0-9873-4B34-8775-F3665B15E21C

Q41494260-9219394C-00D3-49E6-B490-1106BE3C6965

Q41494260-CDAEA8A5-E846-47D0-B57A-8FE7A98D08DD

Q41494260-F65D7B01-2557-4C36-90D6-A5CC0DD77407

P304

Q41494260-910BA604-F4F2-43B7-846E-511A0D5E0559

P31

Q41494260-0551F853-599B-4C5A-94D2-220EC2CB9EFE

P356

Q41494260-E619BFA0-1D90-481B-9410-392BCC528EC1

P407

Q41494260-814D1302-F8F9-4603-B422-D72738CD52BD

P433

Q41494260-3AF350E0-ECF2-4E8B-8EC6-A4756DD7BA34

P478

Q41494260-590A026B-C8A7-4A17-AB4D-543B9E51982C

P577

Q41494260-055F7016-442F-4480-A6B8-850E180A265E

P698

Q41494260-09686B9D-0F64-4F69-A8D0-7CA9ABB16CA7

P932

Q41494260-13130992-2ECE-49F2-BBF3-B8D60B4980A4

P356

BLOOD-2016-03-704304

P1433

P1476

Dissecting stroke for anti-VWF therapeutics.

@en

P2093

Jing-Fei Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke.

Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network.

Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke.

von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.

ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

Deficiency of von Willebrand factor protects mice from ischemic stroke.

Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy.

Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke

P304

2271-2272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-03-704304

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27206666

http://www.w3.org/2001/XMLSchema#string

P932

4865587

http://www.w3.org/2001/XMLSchema#string